Back to search

Ireland· IE-PA-EU/1/08/501/1-2

Ixiaro 6 AU Suspension for injection

A encephalitis, japanische, inaktiviert, ganzes virus product containing inactivated je virus, registered in Ireland by Intercell Austria AG. The same ATC class is registered in 11 of our 19 countries.

ATC J07BA02

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedIxiaro 6 AU Suspension for injectionATCJ07BA02REGISTER NO.IE-PA-EU/1/08/501/1-2PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Encephalitis, japanische, inaktiviert, ganzes virus is registered in 11 of 19 countries.

Countries holding a registration under ATC J07BA02 (encephalitis, japanische, inaktiviert, ganzes virus), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 7 of them publish a price we can compare per daily dose

Encephalitis, japanische, inaktiviert, ganzes virus · ATC J07BA02

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Inactivated je virus
Manufacturer
Intercell Austria AG
Country
Ireland (IE)
ATC code
J07BA02
ATC class
Encephalitis, japanische, inaktiviert, ganzes Virus
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/08/501/1-2

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e887d50a-89c7-4dc1-ba8b-c4bfe9919160
GET /v1/drugs/e887d50a-89c7-4dc1-ba8b-c4bfe9919160?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Suspension for injection",
  "routes": [
    "Intramuscular use"
  ],
  "source": "hpra",
  "atc_all": [
    "J07BA",
    "J07BA02"
  ],
  "strength": null,
  "pa_number": "EU/1/08/501/1-2",
  "substances": [
    "Inactivated je virus"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "31/03/2009",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about encephalitis, japanische, inaktiviert, ganzes virus.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.